Seelos Therapeutics Inc (SEEL)
0.2636
-0.02
(-6.59%)
USD |
NASDAQ |
May 10, 13:04
Seelos Therapeutics Shareholders Equity (Quarterly): -33.51M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -33.51M |
September 30, 2023 | -30.41M |
June 30, 2023 | -47.18M |
March 31, 2023 | -20.66M |
December 31, 2022 | -10.61M |
September 30, 2022 | 7.879M |
June 30, 2022 | 26.23M |
March 31, 2022 | 45.64M |
December 31, 2021 | 57.32M |
September 30, 2021 | 72.91M |
June 30, 2021 | 82.70M |
March 31, 2021 | 24.76M |
December 31, 2020 | 2.572M |
September 30, 2020 | 6.692M |
June 30, 2020 | 3.707M |
March 31, 2020 | 6.765M |
December 31, 2019 | -0.007M |
September 30, 2019 | 10.35M |
June 30, 2019 | 4.939M |
March 31, 2019 | 3.037M |
December 31, 2018 | 2.572M |
September 30, 2018 | 4.113M |
June 30, 2018 | 5.284M |
March 31, 2018 | 4.288M |
December 31, 2017 | 4.371M |
Date | Value |
---|---|
September 30, 2017 | 6.319M |
June 30, 2017 | 6.572M |
March 31, 2017 | 0.842M |
December 31, 2016 | -7.516M |
September 30, 2016 | -7.537M |
June 30, 2016 | -9.441M |
March 31, 2016 | -6.843M |
December 31, 2015 | -9.944M |
September 30, 2015 | -7.911M |
June 30, 2015 | -3.25M |
March 31, 2015 | 1.67M |
December 31, 2014 | 1.919M |
September 30, 2014 | 12.00M |
June 30, 2014 | 11.85M |
March 31, 2014 | 8.89M |
December 31, 2013 | 10.97M |
September 30, 2013 | 11.95M |
June 30, 2013 | 13.39M |
March 31, 2013 | -0.609M |
December 31, 2012 | 6.621M |
September 30, 2012 | 23.54M |
June 30, 2012 | 16.84M |
March 31, 2012 | 20.17M |
December 31, 2011 | 4.818M |
September 30, 2011 | 6.275M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-47.18M
Minimum
Jun 2023
82.70M
Maximum
Jun 2021
11.06M
Average
6.692M
Median
Sep 2020
Shareholders Equity (Quarterly) Benchmarks
180 Life Sciences Corp | -0.1277M |
Acurx Pharmaceuticals Inc | 57.89M |
NovaBay Pharmaceuticals Inc | 3.314M |
Palatin Technologies Inc | -11.38M |
iBio Inc | 9.197M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 5.418M |
Total Liabilities (Quarterly) | 38.93M |